Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...

Cancer researchers have chased the idea of a universal cancer vaccine for decades. The promise sounds bold and almost ...

This year was marked by the resurgence of the Kennedys, one of America’s dynasties, but in unexpected ways from MAHA to ...

From smartphones to artificial intelligence, technology moved from the margins of daily life to its center, transforming how ...

Since he entered politics, President Donald Trump has been a regular on our end-of-year list of the most egregious and noteworthy falsehoods and distortions. With Trump back in the White House in 2025 ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

The era of CureVac as an independent, publicly traded company has drawn to a close. BioNTech SE has successfully completed ...

Maria Branyas Morera, once the world's oldest woman, died in 2024 at age 117. Live Science took a deep look at a study that ...

In this sector, news comes from research — on hair loss, smoking cessation, lupus, gonorrhea — and mergers and acquisitions.

This year, hype around AI really exploded, and so did concerns about AI’s environmental footprint. We also saw some ...

Advances delivered what may feel like medical miracles, including the first bladder transplant, a lifesaving personalized ...

Tantalising signs of past microbial life showed up on Mars this year, but to truly know whether they contain the answer to ...